Meeting
2016 ASCO Annual Meeting
Cell-free DNA sequencing-guided therapy in a prospective clinical trial: NEXT-2 trial—A feasibility analysis.
Authors
Jeeyun Lee
Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea
Jeeyun Lee , Seung Tae Kim , Kyoung-Mee Kim , Won Ki Kang , AmirAli Talasaz , Keunchil Park
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Biomarkers
Clinical Trial Registration Number
NCT02140463
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11534)
DOI
10.1200/JCO.2016.34.15_suppl.11534
Abstract #
11534
Poster Bd #
231
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Genomic alterations after EGFR blockade in patients with RAS wild-type metastatic colorectal cancer: Combined tissue and blood-based analysis from SCRUM-Japan GI-SCREEN and GOZILA.
First Author: Yoshiaki Nakamura
Poster
2018 ASCO Annual Meeting
Upfront next generation sequencing in NSCLC: A publicly funded perspective.
First Author: Kirstin Perdrizet
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of appendiceal adenocarcinoma.
First Author: Kanwal Pratap Singh Raghav